Zhongnan Medical Journal Press

Home Results

A total of 4 result was found. Results that relate to HAN Yutong

Associations among immunophenotype, plasma metabolites, and benign prostatic hyperplasia: a mediation Mendelian randomization study

Published on New Medicine 2025,35(1):73-82.
11202 times 2044 times

FAN Jiuming ZHAO Yiqiao JIA Haichang WANG Tiankun HAN Yutong QI Zihao CHEN Ping ZENG Xiantao

Benign prostatic hyperplasia Mendelian randomization Immunophenotypes Plasma metabolites Exposure-mediator-outcome pathway Mediation analysis
Details
Research progress on mechanisms of endocrine therapy resistance in prostate cancer

Published on New Medicine 2025,35(4):452-460.
15685 times 2500 times

QI Zihao WANG Leijie WU Linjie BAI Xiaojie FAN Jiuming WANG Tiankun HAN Yutong YU Ying GUO Zhongqiang ZENG Xiantao

Prostate cancer Androgen receptor Androgen deprivation therapy Castration resistance Drug resistance mechanism
Details
The role of zinc homeostasis in prostate diseases and potential mechanisms

Published on New Medicine 2025,35(7):846-854.
14140 times 1994 times

HAN Yutong FAN Jiuming WANG Tiankun QI Zihao ZHANG Yuanyuan HOU Junqing

Zinc Zinc Homeostasis Prostatic diseases Prostate cancer Benign prostatic hyperplasia
Details
Establishment of drug utilization evaluation criteria for bemiparin sodium and its clinical application

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):820-827.
2026 times 455 times

YE Chenli HONG Weimin HAN Yutong CAO Weiling

Bemiparin sodium Drug utilization evaluation Delphi method Off-label use Rational drug use
Details